Gastroenterology Thursday 11 November 2010
Venue: Royal College of Physicians of Edinburgh, 9 Queen Street, Edinburgh
Registration and Coffee Welcome by Dr Mike Jones, Vice-President, Royal College of Physicians of Edinburgh Session 1 – How do I manage
Chair: Dr David Nylander, Consultant Gastroenterologist, Sunderland Royal Hospital
C Diff diarrhoea
Professor Chris Probert, Professor of Gastroenterology, Bristol Royal Infirmary ● epidemiology – incidence, morbidity and mortality, cost to NHS ● prevention – antibiotic regimes, isolation wards ● how do I manage metronidazole/standard dose vancomycin treatment failures? role of higher dose oral vanc, role of immunoglobulin, role of steroids
Lower GI bleeding Miss Sarah Mills, Consultant Colorectal Surgeon, Wansbeck General Hospital ● epidemiology ● investigation – who to refer for further investigation of rectal bleeding in the community. Is lower GI investigation required in the acute setting? OGD? ● treatment options, what to do with those lower GI bleeds that keep bleeding (i.e. embolisation/ laparoscopy and colonoscopy on table)? Current treatment strategies for anal fissures/ haemorrhoids 10.30 Fatty
Professor Christopher Day, Professor of Liver Medicine and Honorary Consultant Physician, University of Newcastle ● scale of the problem, fatty liver so what? natural history of disease ● strategy to identify patients already with some cirrhosis/at risk of developing cirrhosis – scoring systems/ fibroscans/ who to biopsy ● current treatment strategies and therapies on the horizon
Coffee / tea Session 2 – Ensuring patient safety
Chair: Dr Christian Dipper, Consultant Physician and Gastroenterologist, Royal Victoria Infirmary, Newcastle
10 years of anti-TNF therapy in IBD: what have we learnt? Professor Jack Satsangi, Professor of Gastroenterology, University of Edinburgh ● what is the known safety profile? ● what are the unanswered questions? ● how to convey information responsibly? ● how to balance risks and efficacy? Bones and steroids Professor Juliet Compston, Professor of Bone Medicine, Addenbrooke’s Hospital. Cambridge ● what are the risks of developing osteopenia/osteoporosis/low trauma fractures if you are taking a) long term steroids b) intermittent steroids but several times a year ● when and how frequently should we be dexa scanning these patients ● does Calcium supplementation when on steroids help, and to what extent? 12.30 Lunch Gastroenterology Thursday 11 November 2010
Venue: Royal College of Physicians of Edinburgh, 9 Queen Street, Edinburgh
AFTERNOON Session 3 – GI therapeutics avoiding waste
Chair: Dr Charles Lees, Consultant Gastroenterologist, Western General Hospital, Edinburgh
5 ASA drugs in Crohn’s disease Dr Miles Parkes, Consultant Gastroenterologist, Addenbrooke's Hospital, Cambridge ● what is the evidence for ASA benefit in Crohn’s? ● is there a group of Crohn’s patients who may benefit? ● is it cost effective? 13.45 Endoscopy
Dr Bjorn Rembacken, Consultant Gastroenterologist, General Infirmary, Leeds ● common pitfalls in endoscopy and polypectomy ● shortcomings of colonoscopy ● shortcomings of our Bowel Cancer Screening programme
STANLEY DAVIDSON LECTURE Chair: Dr Mike Jones, Vice-President, Royal College of Physicians of Edinburgh Patient safety; how can revalidation help? Mr Paul Philip, Deputy Chief Executive, General Medical Council
Symposium feedback / tea Session 4 – New developments
Chair: Dr John Mansfield, Consultant Physician and Gastroenterologist, Royal Victoria Infirmary, Newcastle-upon-Tyne
IBD genetics – translating science into practice Dr Charles Lees, Consultant Gastroenterologist, Western General Hospital, Edinburgh ● review of recent history of IBD genetics ● is IBD a spectrum of several diseases and can the nature of IBD be predicted /determined by genetics? could this help direct treatment in the future? can it inform prognosis? Viral hepatitis – new treatments towards a cure Dr Andrew Holt, Consultant Physician and Hepatologist, Queen Elizabeth Hospital, Birmingham ● current practice in management of Hep B/C, prevalence of treatment failures ● future drugs on the horizon – protease inhibitors for HCV - results from preliminary trials, ?eltrombopag, ??fish oils, ??HCV vaccine 16.25 Close
For further details and to book online: http://events.rcpe.ac.uk
Natural Alternatives to Nexium, Maalox, Tagament, Prilosec and Other Acid Blockers: What to Useto Relieve Acid Reflux, Heartburn, and Gastric Ailments, Martie Whittekin, Square One Publishers,2012, 0757002102, 9780757002106, 262 pages. Written by health professionals who are wellrecognized in their respective fields, these concise, easy-to-read books focus on a wide range ofimportant health conc
Helping you make the most of your drug coverageYour group benefit plan covers drugs listed on the National Formulary. Although it covers approximately 85% of the mostfrequently prescribed drugs in Canada, you may find yourself with a prescription for a drug that isn’t on the list. This isimportant to understand because non-formulary drugs are either covered at a lower percentage, or not covered
Gastroenterology 
Gastroenterology